Xytis
Xytis is a biopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Xytis Information
Geographic Data
Address:
City: Irvine
State: California
Zip:
Country: United States
Financial Info
Stage:
series b
Raised Last:
$25M
Raised Total:$25M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Xytis is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates. The company is privately held and was created in Jan 2006 by the merger of Xytis Pharmaceuticals Ltd. (UK) and Remergent, Inc. (USA). The company received funding from Sanderling Ventures, Atlas Venture, CDC Entreprises Innovation, and Ventech. Xytis Inc. is assembling a pipeline of innovative compounds with validated mechanisms of action, addressing major unmet clinical needs in CNS fields such as Schizophrenia, Traumatic Brain Injury, Depression, Anxiety, or Insomnia. The company has two clinical stage compounds in development and operates from the USA, UK and Switzerland.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2006 | Series B | 4 | $24.5M |
Atlas Venture CDC Enterprises Sanderling Ventures Ventech Atlas Venture CDC Enterprises Sanderling Ventures Ventech |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
